Publicacions en què col·labora amb Alberto Pérez Mediavilla (10)

2021

  1. Identifying the main functional pathways associated with cognitive resilience to alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

2013

  1. Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease

    Current Alzheimer Research, Vol. 10, Núm. 4, pp. 390-405

2012

  1. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice

    Journal of Alzheimer's Disease, Vol. 28, Núm. 3, pp. 567-578

2011

  1. Chronic mild stress in mice promotes cognitive impairment and CDK5-dependent tau hyperphosphorylation

    Behavioural Brain Research, Vol. 220, Núm. 2, pp. 338-343

  2. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in alzheimer's disease transgenic mice: An insight into the pathogenic effects of amyloid-β

    Journal of Alzheimer's Disease, Vol. 23, Núm. 2, pp. 195-206

2010

  1. Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: Mechanisms involving a reduced amyloid and tau pathology

    Neuropsychopharmacology, Vol. 35, Núm. 7, pp. 1593-1604

2009

  1. Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786

  2. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels

    Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378

  3. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an alzheimer's disease mouse model

    Neuropsychopharmacology, Vol. 34, Núm. 7, pp. 1721-1732

2005

  1. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

    Neurobiology of Disease, Vol. 20, Núm. 3, pp. 814-822